In Conversation

The CE region is completely in line with the global strategy, and, in some respects, I would say we are one step ahead of the broader…

Companies choose to work with us because of our dedication, structure, and top-quality services

We are under pressure to develop new products to generate better income which means investing more in research

As health stakeholders, we need to work across the regulatory approval and reimbursement process to explore how healthcare systems can be modified to provide earlier access…

Romania is following the footsteps of other European countries when it comes to digitalization in the self-care market

The Czech Republic is a perfect example of how the generics industry can ensure the sustainability of the healthcare system and reduce costs

The cultures of [both Takeda and Shire], whilst different, shared a central pillar around which we could build the new organization: patient-centricity

Change should be part of our daily life. Genpharm has been always centred around being an agile and dynamic organization

The third part of our innovation agenda, which might also be the toughest one, is to change our own mindset

Mediclinic is a relatively young brand but we have achieved "super brand" status in four out of the last five years

My mission was to rebuild and transform the organization from a “local” company to a highly engaged member of the global Roche group

In this region of the world we have a particular potential to help diabetes and oncology patients

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here